An integrated platform for decoding hydrophilic peptide fingerprints of hepatocellular carcinoma using artificial intelligence and two-dimensional nanosheets.

Journal: Journal of materials chemistry. B
Published Date:

Abstract

Hydrophilic peptides (HPs) play a critical role in the pathogenesis of hepatocellular carcinoma (HCC). However, the comprehensive and in-depth high-throughput analysis of specific changes in HPs associated with HCC remains unrealized, due to the complex nature of biological fluids and the challenges of mining complex patterns in large data sets. The clinical diagnosis of HCC still lacks a non-destructive and accurate classification method, given the limited specificity of widely used biomarkers. To address these challenges, we have established a multifunctional platform that integrates artificial intelligence computation, hydrophilic interaction extraction of HPs, and MALDI-MS testing. This platform aims to achieve highly sensitive HP fingerprinting for accurate diagnosis of HCC. The method not only facilitates efficient detection of HPs, but also achieves a remarkable 100.00% diagnostic accuracy for HCC in a test cohort, supported by machine learning algorithms. By constructing a panel of HPs with 10 characteristic features, we achieved 98% accuracy in the test cohort for rapid diagnosis and identified 62 HPs deeply involved in pathways related to liver diseases. This integrated strategy provides new research directions for future biomarker studies as well as early diagnosis and individualized treatment of HCC.

Authors

  • Zhiyu Li
    Department of Medical Imaging, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 201306, China.
  • Bingcun Ma
    Sichuan Institute for Drug Control, Chengdu 610097, China.
  • Shaoxuan Shui
    National Engineering Research Center for Biomaterials, School of Biomedical Engineering, Sichuan University, Chengdu 610064, China. fanglan@scu.edu.cn.
  • Zunfang Tu
    Sichuan Institute for Drug Control, Chengdu 610097, China.
  • Weili Peng
    Machine Intelligence Lab, College of Computer Science, Sichuan University, Chengdu 610064, China.
  • Yuanyuan Chen
    Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310001, China.
  • Juan Zhou
    Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Fang Lan
    Basic Medical College, Shanghai University of Traditional Chinese Medicine, Pudong, China.
  • Binwu Ying
    Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610064, China. zhoujuan39@wchscu.cn.
  • Yao Wu